Company news

10x Genomics, Inc. (NASDAQ:TXG) news

10x Genomics, Inc. news releases on 6ix. Latest, Feb 25, 2021: 10x Genomics to Present at the 41st Annual Cowen Health Care Conference

View 10x Genomics, Inc. →

Press releases — page 4

10x Genomics to Present at the 41st Annual Cowen Health Care Conference

February 24, 2021

10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event

February 23, 2021

10x Genomics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

February 16, 2021

10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021

January 27, 2021

10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference

December 22, 2020

10x Genomics Reports Third Quarter 2020 Financial Results

November 9, 2020

10x Genomics to Participate in the Stifel 2020 Healthcare Conference

November 3, 2020

10x Genomics to Report Third Quarter Financial Results on November 10, 2020

October 12, 2020

10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions

October 4, 2020

10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome

September 14, 2020

10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

September 14, 2020

10x Genomics Announces Pricing of Upsized Public Offering

September 9, 2020

10x Genomics Announces Launch of a Follow-On Public Offering

September 7, 2020

10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference

August 31, 2020

10x Genomics Reports Second Quarter 2020 Financial Results

August 10, 2020

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit

August 5, 2020

10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

July 13, 2020

10x Genomics to Report Second Quarter Financial Results on August 11, 2020

July 7, 2020

10x Genomics Selects First 45 Members for Visium Clinical Translational Research Network

June 16, 2020

Focusing on the Genes that Matter Most: 10x Genomics Launches Targeted Gene Expression Solution

May 19, 2020

10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing

May 18, 2020

10x Genomics Reports First Quarter 2020 Financial Results

May 10, 2020

10x Genomics to Present at the BofA Securities 2020 Healthcare Conference

May 4, 2020

10x Genomics to Report First Quarter Financial Results on May 11, 2020

April 23, 2020

10x Genomics Provides COVID-19 Business Impact Update and Response

April 8, 2020

10x Genomics Appoints Kim Popovits to Board of Directors

April 1, 2020

10x Genomics to Present at the 40th Annual Cowen Health Care Conference

February 24, 2020

10x Genomics Debuts Range of New Products at AGBT

February 23, 2020

10x Genomics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Revenue Guidance

February 17, 2020

10x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020

February 3, 2020

10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 6, 2020

10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution

November 25, 2019

10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance

November 6, 2019

10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019

October 24, 2019

10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

September 15, 2019

10x Genomics Announces Pricing of Initial Public Offering

September 11, 2019

← Newer